Oral Fluoropyrimidine-Based Combination Therapy in Gastrointestinal Cancer
January 2nd 2001Significant emphasis has been placed recently on designing more effective fluorouracil (5-FU)-based combination protocols for gastrointestinal cancer. Promising results were seen with 5-FU/leucovorin in combination with